Covista (CVSA) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Covista

NYSE•Consumer Defensive•Education & Training Services

$126.50-2.76(-0.02%)After hours

Market Cap

$4.22B

P/E

16.4x

P/S

2.1x

P/B

3.0x

Covista Inc., together with its subsidiaries, provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. It operates in three segments: Chamberlain, Walden, and Medical and Veterinary. The company provides degree programs, including bachelor's, master's, and doctoral degrees; and online certificate programs for nursing, health professions, medical, and veterinary postsecondary education, counseling, business, information technology, psychology, public health, social work and human services, public administration and public policy, and criminal justice. It also operates Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. The company was formerly known as Adtalem Global Education Inc. and changed its name to Covista Inc. in February 2026. Covista Inc. was incorporated in 1987 and is headquartered in Chicago, Illinois.

How this company scores

GoodMetricSide Score: 75/100

Strongest: Cash & Earnings Quality (22/25); weakest: Balance Sheet & Red Flags (16/25).

Profitability20/25

Growth17/25

Balance Sheet & Red Flags16/25

Cash & Earnings Quality22/25

Strengths

Strong marginsHigh ROELow leverageCash-backed earnings

No red flags in the last 8 quarters.

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 16.4x5y range 4.2x – 21.9x

Currently near its 19-quarter median.

P/S · 2.1x5y range 1.0x – 3.0x

Currently above its 20-quarter median.

P/B · 3.0x5y range 1.0x – 3.8x

Price & Volume

Market Cap $4.22B

Metrics at a Glance

as of September 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $2.00B
Q. Revenue: $511.53M
TTM EBITDA: $395.93M
TTM Op. Income: $395.93M
Q. Op. Income: $98.03M
TTM Net Income: $257.16M
Q. Net Income: $67.43M
EPS: $1.99
Shares Out.: $33.95M

$2.00B in TTM revenue grew 9.3% YoY, reaching $511.53M last quarter. TTM EBITDA of $395.93M and TTM operating income of $395.93M show growth is flowing through to the bottom line. TTM net income of $257.16M means revenue is converting into profit. Across the last 8 quarters, TTM revenue has risen for 7 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 56.8%
EBITDA Margin: 19.2%
Op. Margin: 19.2%
Net Margin: 13.2%

Op. margin of 19.2% is up 0.7% YoY — cost efficiency is improving. Net margin at 13.2% and gross margin of 56.8% show how much of each revenue dollar survives to profit. Across the last 8 quarters, operating margin has risen for 2 consecutive quarters — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 16.4x
P/S Ratio: 2.1x
P/B Ratio: 3.0x

At 16.4x P/E, the stock trades within typical market levels. P/S of 2.1x and P/B of 3.0x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Over the past year, P/E is down 25% — an improving trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $2.93B
Cash: $222.22M
Long-Term Debt: $495.13M
Book Value: $1.42B
D/E Ratio: 0.3
Debt/EBITDA: 5.1

With $2.93B in assets and $495.13M in long-term debt, D/E is 0.3and book value is $1.42B — a conservative capital structure with a cushion to weather downturns. Over the past year, debt/equity is down 8% — an improving trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $114.04M
TTM Free Cash Flow: $354.65M
FCF Margin: 17.7%
FCF / Net Income: 1.4

TTM FCF of $354.65M on $114.04M in operating cash flow. The FCF / Net Income ratio of 1.4x means free cash flow covers net income — earnings are backed by cash. Over the past year, free cash flow is up 10% — a weakening trend.